Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe revision tag was updated from v3.6.6 to v3.7.0, marking a new version in the study record's history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the version history, and the previous 'Revision: v3.6.5' entry was removed. This updates the page's historical revision information to reflect the latest change to the study record display.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page history now lists Revision: v3.6.5 in place of v3.6.4, signaling a platform version update to the record history interface.SummaryDifference0.1%

- Check65 days agoChange DetectedThe sponsor subsidiary name is updated from Gossamer Bio Inc. to Gossamer Bio USA, Inc., and the revision/version is updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check87 days agoChange DetectedA new revision, v3.6.3, appears in the record history, indicating an updated version of the page. The previous revision, v3.6.2, is no longer the latest entry in the history.SummaryDifference0.1%

- Check93 days agoChange DetectedA new latest revision v3.6.2 is added to the record history and the older revision v3.6.0 is removed, reflecting an update to the study record's version history.SummaryDifference0.1%

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.